Medtronic Closes $585M Purchase of CathWorks

Medtronic closes $585M purchase of CathWorks

The deal is the second tuck-in acquisition this year for Medtronic, which has signaled its intent to pursue more M&A in its core business lines.

Medtronic Closes on $585M CathWorks Acquisition - Orange County Business Journal

Medtronic today announced that it has closed on its $585 million acquisition of Newport Beach medical device maker CathWorks. “With the acquisition of CathWorks by Medtronic, we are boldly redefining the future of cardiovascular care,” CathWorks Chief Executive Ramin Mousavi said in a statement. The closing of the deal comes four years after both companies entered an agreement to co-promote CathWorks’ FFRangio System where it’s currently availab…

Medtronic Completes Acquisition of CathWorks

April 20, 2026—Medtronic announced it has completed its acquisition of CathWorks, a privately held medical device company focused on the diagnosis and treatment of coronary artery disease with its fractional flow reserve (FFR) diagnostic technology. The company first announced it was exercising its option to acquire CathWorks in a transaction valued at $585 million with potential undisclosed earn-out payments postacquisition in February 2026. In…

Medtronic completes CathWorks acquisition and invests in Pulnovo

Medtronic has completed its acquisition of CathWorks, developer of the FFRangio, artificial intelligence (AI)-powered, non-invasive imaging software for diagnosis and treatment of coronary artery disease (CAD). The acquisition follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio system where it is commercially available in the USA, Europe and Japan. The acquisition is valued at US$585 million with potential undiscl…